News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Live biotherapeutic product (LBP) developer, 4D Pharma, which has been NASDAQ listed since March this year, has announced positive topline results for the first part of its Phase I/II trial of an LBP strain for the treatment of asthma.
As 2021 draws to a close, we take a look at the COVID-19 vaccine development landscape and some of the candidates progressing through clinical trials.
There is a healthy appetite for continued investment in gene therapy, in new modalities and more indications, says an industry insider as he reflected on the prospects for the US gene therapy sector next year.
The pandemic has focused biopharma industry minds on digital innovation, finds a Deloitte report.
Novartis will acquire UK-based Gyroscope Therapeutics, the company behind a one-time investigational gene therapy for geographic atrophy (GA).